Calculus Bolsters Senior Team With New Investment Director
Elizabeth Klein joins Calculus as a Director within the investment team, bringing a wealth of experience.
Elizabeth Klein joins Calculus as a Director within the investment team, bringing a wealth of experience.
Scancell said it has enrolled its first patient in the expansion phase of its ModiFY trial.
Important note: Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. Welcome to our third quarterly update of 2022. This quarter, we are delighted to announce the launch of our HMRC approved Knowledge Intensive EIS Fund, whereby … Continued
Riff Raff Entertainment update on latest project and Brouhaha release first look of ‘Lee’.
Scancell Holdings, Calculus portfolio company, said it has signed a deal worth up to US$208m.
As UK Inflation hits 10.1% John Glencross, CEO of Calculus, Shares his views on the implications.
Wazoku becomes one of the world’s first innovation companies to achieve prestigious B-Corp recognition.
Calculus launches new Knowledge Intensive EIS fund, an HMRC approved Fund.
Oxford BioTherapeutics announce agreement with Genmab to add further depth and momentum into its drug pipeline.
Calculus has launched its new VCT share offer providing investors with access to the innovators and gamechangers who can grow and scale the UK’s businesses of the future.